IP Library Granted Patent US 10,080,884
Granted Patent B2
US 10,080,884 · App. 14/584,066 · Granted Sep 25, 2018

Methods and devices for activating brown adipose tissue using electrical energy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,080,884
App. No.
14/584,066
Granted
Sep 25, 2018
Kind
B2
Abstract

Methods and devices are provided for activating brown adipose tissue (BAT) using electrical energy. In general, the methods and devices can facilitate activation of BAT to increase thermogenesis. The BAT can be activated by applying an electrical signal thereto that can be configured to target sympathetic nerves that can directly innervate the BAT. The electrical signal can be configured to target the sympathetic nerves using fiber diameter selectivity. In other words, the electrical signal can be configured to activate nerve fibers having a first diameter without activating nerve fibers having diameters different than the first diameter. Sympathetic nerves include postganglionic unmyelinated, small diameter fibers, while parasympathetic nerves that can directly innervate BAT include preganglionic myelinated, larger diameter fibers. The electrical signal can be configured to target and activate the postganglionic unmyelinated, small diameter fibers without activating the preganglionic myelinated, larger diameter fibers.

Claims (23)

1. A medical method, comprising:

positioning a device in contact with tissue of a patient proximate to a depot of brown adipose tissue (BAT); and

activating the device to transcutaneously deliver an electrical signal to the patient so as to activate a first nerve type in the BAT without activating a second, different nerve type in the BAT, the first nerve type having a smaller diameter than the second nerve type, and the electrical signal has a peak current that is at least about 50 mA.

2. The method of claim 1 , wherein the first nerve type includes sympathetic nerves, and the second nerve type includes parasympathetic nerves.

3. The method of claim 1 , wherein the first nerve type includes sympathetic nerves, and the second nerve type includes sensory nerves.

4. The method of claim 1 , wherein the electrical signal has a peak current in a range of about 50 mA to 100 mA.

5. The method of claim 1 , wherein the electrical signal has a current of at least 10 mA.

6. The method of claim 1 , wherein the electrical signal has a pulse width less than about 400 μs.

7. The method of claim 1 , wherein the electrical signal is continuously delivered to the patient for at least one day.

8. The method of claim 1 , wherein positioning the device comprises positioning at least a partial portion of the device external to the patient, the method further comprising:

after the delivering of the electrical signal so as to activate the first nerve type in the BAT, removing the device from being in contact with the tissue of the patient;

repositioning the device in contact with tissue of the patient proximate to a different depot of BAT; and

activating the device to deliver a second electrical signal to the patient so as to activate the first nerve type in the different depot of BAT without activating a second, different nerve type in the different depot of BAT.

9. A medical method, comprising:

positioning a device in contact with tissue of a patient proximate to a depot of brown adipose tissue (BAT); and

activating the device to deliver an electrical signal to the patient so as to activate unmyelinated neurons in the BAT without activating myelinated neurons in the BAT, the electrical signal having a current of at least 10 mA.

10. The method of claim 9 , wherein the myelinated neurons have a diameter in a range of about 2 μm to 6 μm.

11. The method of claim 9 , wherein a peak current of the electrical signal is in a range of about 50 mA to 100 mA.

12. The method of claim 9 , wherein the electrical signal has a pulse width less than about 400 μs.

13. The method of claim 9 , wherein positioning the device comprises transcutaneously applying the device to an exterior skin surface of the patient.

14. The method of claim 9 , wherein positioning the device comprises subcutaneously positioning a partial portion of the device within the patient.

15. The method of claim 9 , wherein positioning the device comprises implanting the device entirely within the patient.

16. The method of claim 9 , wherein the device is in continuous direct contact with the tissue of the patient for at least one day with the device continuously delivering the electrical signal to the patient for the at least one day.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056983/0569 →
CHANGE OF NAME Recorded Mar 3, 2017
From: ETHICON ENDO-SURGERY, LLC
To: ETHICON LLC
Reel/Frame 041873/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: ETHICON ENDO-SURGERY, INC.
To: ETHICON ENDO-SURGERY, LLC
Reel/Frame 037540/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2015
From: HARRIS, JASON L.; BAYNHAM, TAMARA C.
To: ETHICON ENDO-SURGERY, INC.
Reel/Frame 034765/0491 →